A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

Boers, G.H.J. et al. Heterozygosity for homocystinuria in premature peripheral and cerebral ocelusive arterial disease. New Engl. J. Mod. 313, 709–715 (1985).

Genest, J.J. Jr., et al. Plasma homocysteine levels in men with premature coronary artery disease. J. Am. coll. Cartiiol. 16, 1114–1119 (1990).

Clarke, R. et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. New Engl. J. Med. 324, 1149–1155 (1991).

Stampfer, M.J. et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. J. Am. med. Assoc. 268, 877–881 (1992).

Kang, S.-S. et al. Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease. Am. J. hum. Genet. 48, 536–645 (1991).

Engbersen, A.M.T. et al. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinaemia. Am. J. hum. Genet. 56, 142–150 (1995).

Selhub, J., Jacques, P.F., Wilson, P.W.F., Rush, D. & Rosenberg, I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J. Am. med. Assoc. 270, 2693–2698 (1993).

Rosenblatt, D.S. in The Metabolic Basis of Inherited Disease (eds Scriver, C.R., Beaudet, A.L, Sly, W.S. & Valle, D.) 2049–2064 (McGraw-Hill, New York, 1989).

Kang, S.-S., Passen, E.L., Ruggie, N., Wong, P.W.K. & Sora, H. Thermolabile defect of methytenetetrahydrofolate reductase in coronary artery disease. Circulation 88, 1463–1469 (1993).

Goyette, P. et al. Human methylenetetrahydrofolate reductase:isolation of cDNA, mapping and mutation identification. Nature Genet. 7, 195–200 (1994).

Goyette, P., Frosst, P., Rosenblatt, D.S. & Rozen, R. Seven novel mutations in the methylenetetrahydrofolate reductase gene andgenotype/phenotypecorrelations in severe methylenetetrahydrofolate reductase deficiency. Am. J. hum. Genet. 56, 1052–1059 (1995).

Daubner, S.C. & Matthews, R.G. Purification and properties of methylenetetrahydrofolate reductase from pig liver. J. biol. Chem. 257, 140–145 (1982).

Davies, J.F. . et al. Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate. J. Biochem. 29, 9467–3479 (1990).

Franken, D.G., Boers, G.H.J., Blom, H.J., Trijbels, J.M.F. & Kbppenborg, P.W.C. Treatment of mild hyperhomocysteinemia in vasculardisease patients. Arterioscler. Thromb. 14, 465–470 (1994).

Kang, S.S., Zhou, J., Wong, P.W.K., Kowalisyn, J. & Strokosch, G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am. J. hum. Genet. 43, 414–421 (1988).

Horton, R.M. et al. Gene splicing by overlap extension. Meth. Enzymol. 217, 270–279 (1993).

Rosenblatt, D.S. & Erbe, R.W. Methylenetetrahydrofolate reductase in cultured human cells. I. Growth and metabolic studies. Pediatr. Res. 11, 1137–1141 (1977).